INTRODUCTION
The mammalian gastrointestinal tract is inhabited by hundreds of species of symbiotic microbes, many of which have a beneficial impact on the host (Kamada et al., 2013; Kau et al., 2011) . The local immune system faces the daunting task of enforcing peaceful coexistence with these microbes while also imposing a staunch barrier to pathogen invasion (Hooper and Macpherson, 2010) . Maintaining this equilibrium involves both the innate and adaptive arms of the immune system as well as non-immunologic protective strategies-e.g., those involving the mucus barrier and antimicrobial peptides (AMPs) . These host-protective mechanisms are counterbalanced by regulatory processes that limit the antibacterial response and prevent collateral damage from inflammation.
The gut microbiota plays an important role in educating and modulating the host immune system (Mazmanian et al., 2005; Schirmer et al., 2016) . Germ-free (GF) mice show defects in multiple specific immunocyte populations, such as Th2 skewing of their CD4 + T cell compartments; compromised innate lymphoid cell (ILC) function; a deficiency in immunoglobulin A (IgA)-producing plasma cells; and, more generally, greater susceptibility to infection (Surana and Kasper, 2014; Hepworth et al., 2013) . The immunologic impacts of few microbial species have been elucidated: segmented filamentous bacteria (SFB) elicit a robust Th17 response (Ivanov et al., 2009; Gaboriau-Routhiau et al., 2009 ); a glycosphingolipid from Bacteroides fragilis inhibits invariant natural killer T cell differentiation ; and specific subsets of CD4 + Foxp3 + regulatory T cells (Tregs) are induced by a range of individual or groups of microbes (Sefik et al., 2015; Faith et al., 2014; Lathrop et al., 2011; Atarashi et al., 2013) . These changes in immunocyte profiles have readily discernible effects on both gut and extra-gut immune responses, whether protective or pathogenic. Thus, there has been great interest of late in harnessing immune system-microbiota crosstalk in the intestine to therapeutic ends. A common approach has been to perform microbiome-wide association studies to search for correlations between particular microbes and particular disease conditions (Kostic et al., 2015; Gevers et al., 2014; Smith, 2015) . Whereas this is, of course, a useful strategy, we decided to take a different approach. Our driving concept was that the co-evolution of the intestinal microbiota and the local immune system for millennia has resulted in a variety of presumably innocuous strategies by which various microbes manipulate immune system activities. Our goal was to begin to uncover these microbial tactics, using a compendious and performant screen.
The approach we chose was gnotobiotic colonization of GF mice with single microbial strains derived from the human gut followed by extensive immunophenotyping and transcriptomic analysis. Whereas this unabashedly reductionist experimental strategy sets aside the combinatorial effects of a complex microbiota, monocolonization renders the complexities of immune system-microbiota interactions more tractable. The numbers of colonizing bacterial species are higher and more stable over time in a monocolonized host than in a host with a diverse microbiota, and the antigenic or metabolic stimulus to the local immune system is consequently stronger. We were seeking not to recapitulate the biology of the human gut but rather to establish a robust, ''sensitized'' readout system that permits screening for human-derived immunomodulatory microbes and molecules.
Our screen focused on human intestinal symbionts that encompassed, as widely as was practical, the genetic diversity of the human gut microbiota.
Ultimately, we monocolonized mice with 53 individual bacterial species representing all five of the major phyla, and we evaluated their effects on the composition and activation of most innate and adaptive immune system cell types as well as on intestinal tissue transcriptomes. We present both a synthetic overview of the extensive dataset generated and three vignettes describing our findings on particular immunomodulatory cell types or molecules.
RESULTS
We set up a systematic screen for immunomodulatory human gut symbionts. GF C57BL/6 mice were bred in an isolator under rigorous microbial monitoring. At 4 weeks of age, eight mice were sterilely transferred to a gnotobiotic isolator, where they were colonized by gavage with one of the study's 62 bacterial strains (Table S1A) . Fifty-three species spanning the known human gut diversity were originally selected for complete analysis; nine additional strains were chosen for focused analysis to determine whether interesting findings were shared across a species. Two weeks after colonization, host response was assessed by immunologic and genomic profiling of colon and small intestine (SI) ( Figure 1A ). Sixweek-old GF mice were regularly analyzed throughout. Standard operating procedures were strictly followed. All experiments included were documented to ensure monocolonization only with the desired microbe by culture and 16S rDNA sequencing. Moreover, feces from 14 randomly chosen experiments were analyzed by deep sequencing and shown to be pure. We have reported all experiments that were documented to be free of contamination. Phenotypes of interest were validated by independent repetition.
Both local and systemic effects on the immune system were examined by analyzing the proportions of 18 cell types from its innate and adaptive arms (Figures 1B and S1; Table S1B ). Five intestinal and lymphoid tissues were examined: SI and colonic lamina propria; Peyer's patches; mesenteric lymph nodes (mLNs); and systemic lymphoid organs (SLOs) (pooled spleen and subcutaneous lymph nodes). CD4 + T cell production of the cytokines Il10, Il17a, Il22, and interferon g (IFNg), and ILC production of Il22 were also measured.
Microbial Selection and Colonization
Fifty-three bacterial species were selected from the Human Microbiome Project to represent the spectrum of phyla and genera in the human gut microbiota and cover the five dominant phyla: Bacteroidetes; Firmicutes; Proteobacteria; Actinobacteria; and Fusobacteria ( Figure 1C ; Table S1A ). Effective gastrointestinal colonization was assessed by culture of fecal material harvested from the colon and, in some cases, from the stomach and oral cavity. Most of the strains introduced orally into GF mice successfully colonized the intestines of the recipients (10 8 to 10 10 colony-forming units [CFUs]/g; Figure 1D ; Table S1C ). Of the seven species not recovered in fecal specimens, five were recovered at other sites. Porphyromonas gingivalis, Prevotella intermedia, and Prevotella melaninogenica were found only in the oral cavity, whereas Helicobacter pylori and Lactobacillus johnsonii resided exclusively in the stomach. Interestingly, these are the anatomic sites in which these species are normally found in mice and humans with a complex microbiota. This existence of niche preferences even in the absence of microbial competition suggests that they derive from organ-specific physical and/or chemical properties that are intrinsically unfavorable for a certain microbe, such as acidity or the availability of particular nutrient types, rather than from competitive fitness. Only two bacteria failed to colonize any site (Eubacterium lentum and Eubacterium rectale).
Commensal bacteria can breach intestinal barriers and can be found in small numbers in gut-draining lymph nodes or systemically (Vaishnava et al., 2008) . This microbial delocalization is facilitated by deficiencies in innate defenses (Vaishnava et al., 2008; Knoop et al., 2015; Wang et al., 2016) and by myeloid cells that actively transport the bacteria, plausibly to enable antigen presentation (Macpherson and Uhr, 2004; Diehl et al., 2013) . Because the ability of various symbionts to partake in extra-intestinal delocalization is unknown, we took advantage of this screen to investigate the ability of the bacteria we studied to delocalize to mLNs and caudal lymph nodes (cLNs), which drain the SI and the colon, respectively, and to the SLO. Strict precautions were taken during dissection to avoid contamination from the gut. A majority (88%) of the species that colonized the gut were detected alive in mLNs ( Figure 1E , top), with no particular preference according to phylum, genus, or aerobe/anaerobe status. A substantial proportion (47%) of gut-colonizing microbes were found alive in the SLO ( Figure 1E , bottom).
Immunologic Changes in Response to Monocolonization with Human Gut Symbionts
The broad screen described above generated 24,255 individual immunophenotypes induced in local or systemic lymphoid organs by the bacteria that successfully monocolonized GF mice and for which complete data were obtained. Figure 2A and Table S2A illustrate the changes in frequencies of immunocyte populations in the colon, highlighting significant changes at a false discovery rate (FDR) of %0.01. The corresponding fold changes (FCs) relative to GF status are summarized in the heatmap in Figure 2B and Table S2B ; results in other tissues are in Figure S2A and Tables S2A-S2C , and individual mouse data are in Table S2D . A patchwork of effects was observed. Some innate cell types varied in response to several microbes, with expansion (e.g., CD103
+ dendritic cells [DCs] ), contraction (e.g., both CD11b + F4/80 + subsets of macrophages and mononuclear phagocytes), or both (e.g., plasmacytoid dendritic cells [pDCs] ). Type 3 ILCs (ILC3s) were affected by only a few microbes, a result consistent with earlier studies reporting microbiota-mediated alterations in Il22 production, but not in overall ILC3 frequency (Lee et al., 2011; Reynders et al., 2011) . Most cells of the adaptive immune system seemed largely unresponsive, at least in terms of abundance, with comparatively infrequent and modest changes in the proportions of B, gdT, and abT (T4 or T8) cells. The notable exceptions were Tregs and their subsets, which, in line with previous reports (Lathrop et al., 2011; Faith et al., 2014; Sefik et al., 2015) , were strongly induced by a number of individual microbes. These effects were distributed (legend continued on next page) among the different microbes tested, with a range in the number of cell types affected by a given microbe (as judged by the proportion of cell types modified by a Z score of R2 relative to GF; Figure 2C ). Some microbes seemed stealth-like, affecting few or none of the immunocyte populations examined (e.g., Peptostreptococcus magnus and Bacteroides salanitronis), but others were substantially more active (Bacteroides uniformis). Microbes of the same phylum or genus provoked no obviously shared patterns of these signatures in terms of either the number of cell types affected ( Figure 2C ) or the extent of change relative to GF ( Figure 2B ; Table S2B ). In addition to quantitative changes, we observed with a few microbes some reproducible alterations in the configuration of cell populations within flow cytometry counting gates, as illustrated by the difference in CD11c intensity in CD11b Table S2C ). These changes occurred independently of the quantitative perturbations measured above. We assessed the induction of inflammatory or suppressive cytokines by CD4 + T cells and ILCs; because the staining panels were designed before defined markers for ILC subsets had been established, we assessed only bulk ILC populations ( Figure 2E ). Only a handful of symbionts elicited deviations from GF levels in T cells, including (as expected) SFB and Th17 cells (Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009 ), but other unprecedented associations were found, such as Coprobacillus with Il10 + SI T cells
and Bifidobacterium longum with colonic Th1 (T4.IFNg + ) cells ( Figure 2E ). Bacterial influences on Il22 production by ILCs were far more pronounced, with significant induction by microbes such as Bacteroides dorei and B. longum in both gut tissues. Conversely, Acinetobacter lwoffii, Clostridium sordellii, and Veillonella appeared to repress Il22 production, especially in the colon-a result indicating that the microbes can have differential effects on ILC activation. These observations provide a nuanced perspective on bacterial modulation of ILCs and may explain discrepancies in studies comparing Il22 production in GF and specific pathogen-free (SPF) mice (Satoh-Takayama et al., 2008; Lee et al., 2011; Sawa et al., 2011) .
Fecal IgA was quantitated at the end of the 2-week monocolonization. All IgA levels ranged between GF and SPF. Fold change relative to GF is shown in Figure 2B . IgA induction varied by organism and did not follow microbial phylogeny. Total IgA was measured in fecal samples by ELISA, and organismspecific IgA was evaluated by flow cytometry ( Figure S2F ). There was a significant correlation between total and organism-specific IgA (r = 0.51; p = 0.025). This suggests that microbes induce IgA production by acting as standard ''immunogens'' rather than as bystanders that boost IgA production without being direct targets themselves.
Further insight was obtained by correlating the responses induced by the set of microbes in the colon and the SI (Figure 3A) Bacteria of the same phylum or genus provoked no obviously shared patterns of signatures in terms of either the number of cell types affected ( Figure 2C ) or the extent of change relative to GF ( Figure 2B ; Table S2B ). We correlated the normalized immunophenotypic responses between microbes in the SI and the colon ( Figures 3D and S3B ). The dendrogram generated by hierarchical clustering of these correlations bore testament to the true diversity of microbial functions represented by the organisms chosen for this screen. Bacterial species from the same phylum or genus largely failed to cluster together, a result pointing to a high degree of diversification in immunomodulatory properties within a phylum or genus. For seven species (nine strains total), we looked at the impact of additional strain(s) on lymphocyte populations, such as Tregs. For the Bacteroides strains within the same species, we found quantifiable differences (Table  S2D ). The mean Euclidean distance between species was 0.39. Interestingly, the mean distance between strains within the same species was very similar-0.32. These results highlight the importance of strain-level information in relating microbial function to immunologic phenotypes.
Effects of Bacterial Colonization in Systemic Lymphoid Organs
Immunocytes can migrate from the colon into the lymphatics and circulate between lymphoid organs (Morton et al., 2014) . We analyzed immunocyte populations in the mLNs and the SLO to determine whether immunologic alterations in the gut were reflected systemically. Most microbes had a limited effect on innate immunocytes in mLNs and the SLO ( Figure S2B ), although monocytes did vary markedly in the SLO. As in the intestine, adaptive immunocytes in lymphoid organs were mostly unaffected by microbial exposure. To detect more sensitively the echoes in lymphoid organs of microbe-instructed immunologic changes in the gut, we correlated the immunologic phenotypes in the gut and secondary lymphoid organs ( Figures 3B and S3A ). There was a significant correlation across all tissues for five cell types. Table S1 and Figure S1 . 
Feces
(legend on next page) SLO were subtle but were correlated with frequencies in the gut across the set of microbes ( Figure 3B ). This finding suggested a direct relationship between the two pools. The fifth cell typethe monocyte-was the exception, with equally strong induction by C. sordellii in the SLO and the intestines ( Figure 3C ).
Colonic and SI Transcriptomes of Monocolonized Mice
We next investigated the transcriptomic changes induced by the various microbes in SI and colonic tissue. Gene-expression profiles were generated in duplicate from whole-tissue RNA in order to capture responses in all major cell types, with controls from GF tissues included in every batch. We found more marked inter-individual variability in intestinal tissues than in other tissues we have recently profiled, such as fat and muscle (data not shown). Groups of variable genes appeared in the plot of genewise coefficients of variation (CV) ( Figure 4A ): one group had the same variability in replicates of GF and monocolonized mice, but a larger group was more variable in GF colons than in microbially colonized colons, as if the presence of bacteria stabilized fluctuations in the transcriptome. Except for some B-cell-specific transcripts, most of these highly variable genes could not be ascribed to fluctuations in the frequency of particular cell types.
This degree of background variation made the determination of microbe-specific effects somewhat more complicated, but clear effects were apparent in volcano plot representations (Figures S4A and S4B) . We opted for a general approach, flagging transcripts with an FC relative to GF > 2.5 (or <0.4) and uncorrected p(Àlog 10 ) > 2.5 for at least one bacterium. This selection yielded an unexpectedly small number of transcripts, indicating that symbiotic bacteria have only limited effects on the gut transcriptome in the monocolonization setting: 128 genes were upor downregulated in the colon and 116 in the SI, of which 20 were responsive in both colon and SI (Table S3 ). These transcripts are displayed for each microbe in Figures 4B and 4C. None of them was uniformly induced by all bacteria, but >60% of these responsive transcripts were induced by some microbes and repressed by others (e.g., Defa5, Retnlb, Apoa1, and Lyz1 in the colon; Retnlb, Duox2, and Reg3a in the SI). This observation indicated that different microbes can sometimes have diametrically opposed consequences. Some bacteria may take advantage of the host's adaptive abilities as a means of out-competing other microbes, either by creating a more favorable environment for themselves (Rakoff-Nahoum et al., 2016) or by downregulating host metabolic pathways, such as those for lipid or amine metabolism, to create a hostile environment for other bacteria that require these molecules.
Some bacteria had stronger and more reproducible signatures (e.g., Fusobacterium varium in the SI and Campylobacter jejuni in the colon), whereas others had weaker and more variable imprints (Bacteroides salanitronis and Clostridium perfringens). None of the transcripts was uniquely induced by a single microbe, but most were induced (or repressed) by several bacteria, with no particular connection to phylum. In these respects, the diversity of transcriptional changes mirrored the alterations in immunophenotypes described above. These transcriptomic changes could be grouped in co-regulated gene clusters (Figures 4B and 4C) . Cross-referencing to gene expression databases (ImmGen and GNF atlases) showed that some, but not all, of these clusters were predominantly expressed in particular cell types and probably corresponded to responses in those cells (e.g., stromal, macrophage, B cell, or perhaps even stem cell transcripts; Figures 4B and 4C ). In both tissues, the responsive genes encoded a variety of functional molecules-AMPs, stress response elements (Retn, Retnla, and Retnlb), hemoglobins (likely reflecting changes in vascularization), immunoglobulin-related transcripts, and enzymes and molecules involved in lipid metabolism (fat digestion and absorption, lipid processing, lipase, and phospholipase activity)-with corresponding overrepresentation of Gene Ontology pathways (antimicrobial response, extracellular matrix organization, amide and amine metabolism, retinol and vitamin metabolism, and acute inflammatory response). There was also an enrichment in transcripts reported to be affected in infant mice secondary to maternal colonization (Gomez de Agü ero et al., 2016). On the other hand, we did not observe significant induction of inflammationassociated cytokines like Il1a, Il1b, Il6, Il22, tumor necrosis factor (TNF), Il12, or IFNs. (Levels of Il1a, Il22, and Il6 were below detection.) However, Il18 levels were slightly elevated in response to several different bacteria ( Figures S4C and S4D ).
Immunomodulatory Cell Types and Transcriptional
Responses Some interesting observations that we think merit emphasis are presented. Colonic pDCs Are Biased by Gut Bacteria Plasmacytoid dendritic cells are distinctive players in the innate arm of the immune system, playing a central role in antiviral defenses through their ability to produce copious amounts of type I IFNs. Correspondingly, they have been implicated in several IFN-linked diseases (Swiecki and Colonna, 2015) . The influence of the gut microbiota on the pDC pool is largely unknown. One report described a reduction in pDCs in mice with a restricted microbiota distinct from that typical of SPF mice (Fujiwara et al., 2008) , whereas another study revealed induction of pDCs in mLNs by B. fragilis during ongoing colitis (Dasgupta et al., 2014) . Among the myeloid populations, pDCs Figure S2 and Table S2 . had the greatest range of fluctuation in our screen (Figure 2A ), as exemplified by the cytofluorometry profiles in Figure 5A . These fluctuations were bidirectional ( Figure 5B) : 38% of the bacteria tested increased colonic pDC proportions (by R2-fold) in monocolonized mice over those in GF mice, whereas 8% reduced colonic pDC proportions by >2-fold-most extremely in mice colonized with Staphylococcus saprophyticus and Lactobacillus rhamnosus, which harbored almost no pDCs. However, these frequencies were quite variable, even in mice colonized by the same organism. For instance, Bacteroides vulgatus (American Type Culture Collection [ATCC] 8482) was the most potent species at inducing colonic pDCs on average (mean, 6.4% pDCs) but with a range from 1.7% to 14.7%. The recalibration of pDCs in the colon resulting from monocolonization was more variable than the recalibration of CD103 + DCs in the same mice ( Figure S5 ). Interestingly, the ability of a microbe to induce pDCs in the SI and the colon was significantly correlated (r = 0.52; t test p = 0.00061; Figure 5C ); this correlation suggests that the same mediators or pathways might be at play in the two organs. pDCs have significant tolerogenic potential and can stimulate Tregs (Reizis et al., 2011) , an ability that has been associated with type I IFN production (Metidji et al., 2015; Kole et al., 2013; Nakahashi-Oda et al., 2016) . Also of interest was the significant correlation between the strains' ability to boost colonic pDCs and total Foxp3 + Treg frequencies (r = 0.46; t test p = 0.003; Figure 5D ). Next, we identified the sets of genes whose expression was most correlated with pDC frequencies in the SI or the colon, information that we thought might yield insights into the molecular pathways through which microbes modulate pDCs and/or the physiological consequences of their pDC levels. No clear cluster of outliers stood out in these correlations. However, a set of IFN-inducible signature transcripts showed an enhanced correlation with pDC frequencies in both the SI and the colon ( Figure 5E , red dots), which was likely a reflection of their characteristically abundant IFN production. This set of genes ( Figure 5F , left panel, green dots; Table S4 ) included a few interesting transcripts worth highlighting. One transcript, Il18, was noteworthy given that pDCs express high levels of Il18R2 and that Il18 antagonizes their production of type I IFN. One might speculate that Il18 induced by some microbes can promote pDC accumulation rather than effector function (Chao et al., 2014) . Another transcript was Tigit, an activation marker on T cells whose particular expression on Tregs may relate to the correlation between pDC and Treg proportions. Overall, the transcripts most correlated with pDC frequency were enriched in lipid or protein digestion and metabolic pathways (Figure 5F, right panel) , an observation suggesting a connection between pDCs and the metabolic and nutrient uptake functions of the gut.
Antimicrobial Peptide Expression upon Microbial Colonization
Expression of many gut AMPs is constitutive, although bacterial colonization can induce a subset of these peptides in SI Paneth cells (Bevins and Salzman, 2011; Gallo and Hooper, 2012) . We asked whether AMPs respond similarly to different bacterial species and whether they are coordinately regulated in the SI and the colon. In GF mice, a-defensins, Reg3 family members, and other Paneth-cell-derived products (such as Ang4) were expressed at reproducibly high levels in the SI but at 20-fold lower levels in the colon (Figure 6A ), where they were among the most variably expressed transcripts genome-wide (as indicated by their reproducibly high CV; Figures 6A and 6B ) In contrast, b-defensins, which are produced by many types of epithelial cells (Bevins and Salzman, 2011; Gallo and Hooper, 2012) , were expressed at comparable levels in the SI and the colon.
We then assessed the impact of bacterial exposure on AMP transcription in the intestines. The property of high variability in the GF colon was maintained upon microbial exposure (Figure 6B) . Expression of most AMPs was not substantially affected in the SI of any of the monocolonized mice, with only a modest induction of Reg3 family transcripts by a few bacterial species ( Figure 6C ). The most profound change in the SI was a downregulation of all three Reg3 genes by F. varium. In marked contrast, AMP expression was more responsive in the colon, with changes extending significantly beyond the baseline fluctuation in GF colons ( Figure 6D ). Many a-defensin (but not b-defensin) transcripts were coordinately induced by a few phylogenetically diverse species (e.g., Parabacteroides merdae and Porphyromonas uenonis), with a similar pattern for the Reg3 family.
As denoted by the high CV of AMP transcripts in the colon (Figure 6A) , individual GF mice manifested substantial differences in the expression of a-defensin and Reg3 genes. This fluctuation in AMP levels, even in the absence of microbes, suggested that other triggers were affecting their expression. To elucidate the source of this variability, we searched for other genes whose expression correlated with AMPs across the colons of either GF or monocolonized mice ( Figure 6E , left panel). There was no correlation with the expression of IFN signature genes, which would have indicated enteric viral infections, or with Il22 transcripts, which would have suggested stimulation of epithelial cells by ILCs via Il22. A group of genes stood out as most strongly correlated with AMPs in both GF and colonized mice; pathway analysis of these transcripts revealed a significant enrichment in a number of nutrient transport and lipid metabolism pathways, suggesting a link among nutrition, enterocyte function, and AMP production ( Figure 6E , right panel; Table S5 ). Thus, colonization by some symbionts elicits highly coordinated AMP expression in the colon over a fluctuating See also Figure S4 and Table S3 .
background that appears to reflect intestinal function rather than microbial stimulation. Fusobacterium varium Elicits an Unusually Strong Host Response Signature It was clear from the gene expression data of Figures 4 and 6 that F. varium was one of the more stimulatory bacteria. Interestingly, F. varium also influenced many immune cell populations in the colon ( Figures 2B and 2C , especially double-negative [DN] T cells). F. varium is a gram-negative obligate anaerobe in the phylum Fusobacteria. In the SI, monocolonization with this species stood out, with a concentrated suppression of genes within cluster 2 and a strong upregulation of cluster 7 ( Figure 4C ). In the colon, its effects were also strong, albeit less unusual (Figure 4B) .When the SI transcriptomes of mice colonized with F. varium (AO16) were compared with the transcriptomes of any other monocolonized mice, 35% of the genes were more strongly induced ( Figure 7A ). Seven percent of this set of genes was also more intensely induced in the colon by F. varium than by other bacteria ( Figure 7A ).
We investigated the functional nature of the response to F. varium by clustering (in the String database) the sets of transcripts down-or upregulated by F. varium in either the SI or the colon ( Figures 7B and 7C) . Overall, there were a few altered genes related to immune function. Repressed transcripts included a large set related to bile acid metabolism, with a sizable cluster of the Cytochrome p450 gene family (e.g., Cyp3a25 and Cyp2b10) and retinol metabolism genes (e.g., Rdh7 and Aldh1a1; Figure 7B ). Cytochrome p450 controls mechanisms of xenobiotic metabolism in the gut (Carmody and Turnbaugh, 2014) and, together with other members of this cluster (e.g., Rdh7 or Aldh1), influences the metabolism of all trans-retinoic acid. F. varium also strongly repressed the Reg3 antimicrobial family, particularly in the SI (Figure 6C and 7B) . One can speculate that an advantage is gained by F. varium in suppressing these AMPs, which are thought to play an important role in barrier integrity and are usually induced by microbes (Wang et al., 2016; Vaishnava et al., 2008; Cash et al., 2006) . Perhaps F. varium suppresses Reg3 to avoid death induced by AMPs, creating See also Figure S5 and Table S4 . Table S5 . a more favorable milieu for itself. Upregulated genes include those involved in arachidonic acid metabolism (e.g., Alox5ap; Figure 7C ), the essential precursor for lipid mediators of inflammation.
In accordance with the transcriptional effects, F. varium had one of the largest phenotypic impacts (Figures 2B and 2C) . Specifically, it had the strongest effect on abT cells, reducing both T4 (CD4 + ) and T8 (CD8 + ) populations and causing a higher frequency of colonic DN (CD4 À CD8 À TCRb + ) cells than any other microbe ( Figures 7D and 7E) .
Fusobacterium spp. are among the few intestinal symbionts that can be found in both vertebrates and free-living bacterial Tables S6A and S6B. communities, rendering them potent to introduce evolutionarily honed functions (Ley et al., 2008) . Relatively little is known about the Fusobacterium genus and human health, but Fusobacterium nucleatum is prevalent among patients with colorectal carcinoma and among some patients with inflammatory bowel disease (Kostic et al., 2013; Strauss et al., 2011) . The virulence and invasiveness of F. nucleatum strains vary via unknown mechanisms that do not fit subspecies classifications (Strauss et al., 2011) , and the strain of F. nucleatum used here (F0419) elicited no outstanding phenotypes in our study. However, F. varium's prominent signature supports the notion that members of this genus may have unique interactions with the host.
DISCUSSION
The driving concept of this study was that the gut microbiota hosts a largely untapped wealth of immunomodulatory activities. To provide proof of concept, we devised a sensitive, broadranging screen that entailed monocolonization of mice with human gut symbionts followed by extensive, unsupervised immunophenotyping and transcriptomics. Indeed, a screen of 53 bacterial species yielded a number of activities, both anticipated and unanticipated. For example, we found individual microbes capable of inducing Th17 cells in the SI to a level similar to that driven by SFB, as is explored in depth elsewhere (Tan et al., 2016) . Unexpected was the observation that about one-quarter of the bacteria examined, encompassing a diversity of species, could induce RORg+HeliosÀ Tregs in the colon (Sefik et al., 2015) , given claims that a consortium of 17 Clostridium species or several limited individual members of the microbiota are needed for Treg induction (Atarashi et al., 2013; Faith et al., 2014) . Other potentially interesting immunomodulatory activities have not been reported previously-e.g., the augmentation of Il10-producing CD4 + T cells and the parallel reduction of Il22-producing ILCs in the colon by Veillonella, the impressive reduction of pDC numbers by L. rhamnosus, and the unusually strong and broad immunoperturbing activity of F. varium. Thus, this approach has the potential to yield an apothecary of immunomodulatory agents tailored to modulate the immune system in a chosen manner. No doubt local gut effects will be the most straightforward to achieve, but precedents indicate that microbiota manipulations can regulate gut-distal immune responses-both protective and pathogenic (Wu et al., 2010; Ochoa-Repá raz et al., 2010; Hsiao et al., 2013) . Future efforts will be devoted to evaluate selected immunomodulatory microbes in hosts with a substantially more complex intestinal microbiota than monocolonized mice, particularly humans. Data on RORg + Helios À Tregs and Th17 cells argue that at least some of the observed activities can be recapitulated in SPF mice (Sefik et al., 2015; Tan et al., 2016 ). An alternative strategy would be to identify molecules and pathways underlying the immunomodulatory activity of interest. The value of this microbiota-based apothecary will increase in parallel with our molecular and cellular understanding of the immunologic diseases we aim to target, allowing a more precise choice of immunomodulatory activity. Lastly, it will be interesting to see whether extending the screen beyond the 53 bacterial species evaluated here will identify additional activities.
Beyond these practical considerations, our data provide several insights into immune system-microbiota interactions in the gut. The enormous complexity of the intestinal microbiota means that isolating the impact of a particular bacterial species on the intestinal or systemic immune system is a rather daunting task. Our reliance on gnotobiotic conditions aids such deconvolution. Importantly, we found that, in the absence of competition, most of the tested bacteria were able to robustly colonize the mouse intestine and that the great majority of them elicited immunophenotypic and/or transcriptomic changes, whereas few were stealth to the parameters measured. We had previously reported (Chung et al., 2012 ) that mice colonized with a complex human microbiota had small-intestinal immune systems characteristic of GF mice. In contrast, here, we show that colonization with single microbes derived from the human intestine does influence the immune system in the gut of host mice. We ascribe the different outcomes to the much higher load of any one bacterium (up to 10,0003 higher in monocolonized mice than in ''human microbiota'' mice), providing much greater antigen or metabolite stimuli.
Another message conveyed by our data is that immune system recalibration to the microbiota shows substantial diversity and redundancy. On one hand, most microbes elicited a distinct immunophenotype in the host; on the other hand, many immunologic alterations were induced by more than one microbe, and bacteria could be found with opposite effects in most parameters. We speculate that these adaptations might explain why microbial communities are so vast, providing balance to both the community and the host. A sufficiently large community of diverse genomic inputs allows buffering in case certain community members are lost. The broad diversity and redundancy of immunologic alterations permit many different microbes to provide the balance needed to promote overall host health. Importantly, both the diversity and the redundancy can be provided by organisms from the same or different phyla. Similarly, none of the transcriptional effects were induced by all of the microbes. In fact, different bacteria often had opposing impacts on the gut transcriptome-for example, AMP gene expression. There did not appear to be a phylogenetic relationship in either the immunologic or the genomic changes. The lack of a relation between microbe-induced immune recalibration and microbial phylogeny would also contribute to stabilization of the microbiota's influence even if specific taxa were lost. The bacteria examined induced both shared and unique responses in different tissues at both the transcriptional and the cellular levels. For example, for Tregs and pDCs, a strong correlation existed between the SI and the colon (and other tissues). However, for Il17, Il22, and ILCs, recalibration and transcriptional responses to bacteria were mostly restricted to the SI. Interestingly, the finding of greater variability between gene-expression profiles in GF mice than in monocolonized mice supports the contention (Quackenbush, 2002) that the presence of microbial communities stabilizes both immunologic and transcriptional phenotypes and provides resistance to perturbation. This notion of coupled diversity and redundancy may also explain why it is so often difficult to distill a designated microbiota influence or state of dysbiosis down to a single (or a single set of) bacterial species.
The absence of outcomes shared by all species within a phylum, or even a genus, suggests that this interspecies diversification might have occurred through horizontal transfer and/or that the corresponding mechanisms/pathways are common in the bacterial world. Moreover, our study shows differences even among the strains of the same species. This highlights the importance of strain specificity's being associated with immunophenotypes. Even in parallel colonizations with the same microbes, we observed some differences. It is certainly possible that the bacterial and host transcriptomes adapt at different rates and that factors other than the ones we controlled for, such as microbial load, host age, and duration of colonization, are important in stabilizing responses.
This study is remarkable in demonstrating that the gut microbiota presents many opportunities to impact the host immune system. It is clear that multiple individual microbes have important effects on the host and that a balance of the microbiota is necessary for homeostasis. It would be interesting to study the combinatorial effects of immunomodulatory microbes both in a gnotobiotic setting and also under SPF conditions. Determining the minimal consortium of microbes that can maintain a stable balance between the microbiota and the host immune system will likely now be possible. By having identified individual effector strains, future studies on the mechanisms of host/microbial interactions (pathway interactions and key molecules) are vital questions to be answered. Can one rationally control the microbiota to prevent and/or cure disease states by treating with certain desired microbes or molecules? The advantage of using specific molecules, which can be dosed and regulated as any drug, would yield host responses that are more reproducible and therefore advantageous over using viable bacteria to modify or regulate a given host response.
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STAR+METHODS KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-mouse CD8a Alexa 700 Biolegend Cat#100730
Anti-mouse CD4 Alexa 700 Biolegend Cat#100406
Anti-mouse CD45 Brilliant Violet 605 Biolegend Cat#103140
Anti-mouse CD4 FITC Biolegend Cat#100406
Anti-mouse CD19 APC Cy7 Biolegend Cat#115530
Anti-mouse TCRb chain PE Cy7 Biolegend Cat#109222
Anti-mouse CD11c PE Cy7 Biolegend Cat#117318
Anti-mouse/human CD11b Percp Cy5.5
Biolegend Cat#101228
Anti-mouse Ly6c FITC Biolegend Cat#128006
Anti-mouse CD103 PE Biolegend Cat#121406
Anti-mouse CD45 Pacific blue Biolegend Cat#103126
Anti-mouse F4/80 Alexa 700 Biolegend Cat#123130
Anti-mouse CD137(PDCA-1) Alexa Fluor 647
Biolegend Cat#127106
Anti-mouse IL17A APC Biolegend Cat#506916
Anti-mouse IFNg FITC Biolegend Cat#505806
Anti-mouse IL10 Pacific blue Biolegend Cat#505020
Anti-mouse IL22 PE Biolegend Cat# 516404
Anti-mouse TCRgd Percp Cy5.5 Biolegend Cat#118118
Anti-mouse CD45 APC Cy7 Biolegend Cat#103116
Anti-mouse Helios Pacific blue Biolegend Cat#137220
Anti-mouse/rat Foxp3 APC Affymetrix/eBioscience Cat#17-5773-82
Anti-mouse/human ROR gamma (t) PE 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Dennis Kasper (dennis_kasper@hms.harvard.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Bacteria
Bacteria were obtained from several sources: the ATCC (https://atcc.org), BEI (https://www.beiresources.org), or DSMZ (https:// www.dsmz.de) repository or were obtained from BWH clinical labs or Harvard-affiliated labs (Table S1 ). Anaerobic bacteria were cultured in peptone-yeast-glucose (PYG) broth under strictly anaerobic conditions (80% N 2 , 10% H 2 , 10% CO 2 ) at 37 C in an anaerobic chamber. All bacteria (Bacteroides, Clostridium, Bifidobacterium, Lactobacillus, Enterococcus, Fusobacterium, Propionibacterium, and Peptostreptococcus spp.) were grown in PYG medium supplemented with hemin and vitamin K or on brucella blood agar plates and TSA blood agar plates (BBL). Acinetobacter spp. were grown in Super Broth (SB) medium and on LB agar plates. Lachnospiraceae, Veillonella spp., and Coprobacillus spp. were grown in chopped meat broth. Staphylococcus spp. were grown aerobically at 37 C in L-broth and on LB agar plates. Campylobacter and Helicobacter spp. were grown on brucella blood agar plates (VWR) and kept in microaerophilic conditions (CampyPak EZ in an anaerobic container system) at 37 C. The cladogram was generated using Human Microbiome Project data in GraPhlAn (http://huttenhower.sph.harvard.edu/galaxy/) and MetaPhlAn version 1.1.0 (http://www.hmpdacc.org/HMSMCP/healthy/#data). The overall mean diversity calculated by MEGA6 was 0.472. The total mean abundance was 62.6 and the prevalence ranged from 1.4 to 100 with a median of 64.4.
All strains of bacteria that were not from international repositories (Table S1A) were deposited to BEI resources (https://www. beiresources.org/).
Mice GF C57BL/6J mice were originally purchased from the National Gnotobiotic Rodent Resource Center of the University of North Carolina at Chapel Hill, and bred in our lab facility at Harvard Medical School in GF flexible film isolators (Class Biologically Clean) throughout this study. Sterility tests (culture and PCR) were done every week, ensuring that mice remained GF. Mouse food was autoclaved at 128 C for 30 min at 26 PSI. Water was autoclaved at 121 C for 1 hr. SPF mice were housed under the same conditions in the same facility with the same food (autoclaved to ensure comparable nutrients) for 2 weeks. Animals of both genders were used as available. Littermates were randomly assigned to experimental groups, to avoid any bias, whenever possible. Animal protocol IS00000187 and COMS protocol 07-267 were approved by Harvard Medical School's Institutional Animal Care and Use Committee and the Committee on Microbiological Safety, respectively. This study adheres to the ARRIVE guidelines.
Generation and processing of monocolonized mice GF C57BL/6 mice were orally inoculated by gavage with a broth-grown single bacterial strain at 4 weeks of age and kept in gnobiotic isolators. Each group of mice was housed in gnobiotic isolators under sterile conditions for 2 weeks. Fecal material was collected and plated at 1 week and 2 weeks after bacterial inoculation to ensure monocolonization by a single bacterial strain. The identity of all colonizing microbial species was confirmed by 16S sequencing using the 27F and 1492R primers and Sanger sequencing at the Harvard Biopolymers Facility. All colonizations were done and processed at the same time of the day to reduce diurnal variability. Processing was undertaken by the same individuals throughout these studies to minimize person-to-person variability.
METHOD DETAILS Preparation of lymphocytes and flow cytometry
Intestinal tissues were treated with 30 mL of RPMI containing 1 mM dithiothreitol, 20 mM EDTA, and 2% FBS at 37 C for 15 min to remove epithelial cells. The intestinal tissues and Peyer's patches were then minced and dissociated in RPMI containing collagenase II (1.5 mg/mL; GIBCO), dispase (0.5 mg/mL), and 1% FBS, with constant stirring at 37 C (45 min for colons and small intestines; 15 min for Peyer's patches). Single-cell suspensions were then filtered and washed with 4% RPMI solution.
Mesenteric lymph nodes (mLNs), and systemic lymphoid organs (SLO) were mechanically disrupted. Subcutaneous (inguinal and axillary) lymph nodes and spleens were pooled and red blood cells were lysed. To minimize variability and reagent drift, collagenase II and dispase were purchased in bulk and tested for consistency in digestion and viability of cells before use. Single-cell suspensions were stained for surface and intracellular markers and analyzed with BD LSRII.
Single-cell suspensions were stained with three constant panels of antibodies for consistency. The first panel included antibodies against CD4, CD8, TCRß, CD45, TCRgd, CD19, Foxp3, Helios, and Rorg. The second panel included antibodies against CD45, CD4, TCRß, TCRgd, Il17a, IFNg, Il22, and Il10. The third panel included antibodies against CD45, CD19, CD11c, CD11b, Ly6c, PDCA-1, F4/ 80, and CD103. For cytokine analysis (second antibody panel), cells were treated with RPMI containing 10% FBS, phorbol 12-myristate 13-acetate (10 ng/mL; Sigma), and ionomycin (1 mM; Sigma) in the presence of GolgiStop (BD Biosciences) at 37 C for 3.5 hr. For intracellular staining of cytokines and transcription factors (first and second antibody panels), cells were stained for surface markers and fixed in eBioscience Fix/Perm buffer overnight, with subsequent permeabilization in eBioscience permeabilization buffer at room temperature for 45 min in the presence of antibodies. Cells stained with the third panel of markers were fixed in 1% formalin diluted in DMEM overnight. Great care was taken to reduce variability and reagent drift in all enzymes, reagents, and antibodies. Cells were acquired with a BD LSRII, and analysis was performed with FlowJo (Tree Star) software.
Compensation for each experiment was adjusted with Rainbow Calibration particles to ensure consistency in data collection. The concentration, clone, and source of antibodies were kept constant to ensure consistency in staining. Occasionally, the entire set of data was sampled and reanalyzed blindly to ensure equal gating criteria and scoring. The raw data were independently analyzed by two individuals, and an average value was reported. Each analyst used the same version of FlowJo Software and the same bio-exponential settings previously determined for each experiment. In rare cases of disagreement (i.e., when independent scoring differed by R 25%), the scoring was re-determined by the two analysts together in order to understand and resolve the variation. If the disagreement could not be resolved, the data were excluded from the final reports. Any strong discrepancies in staining due to reagent drift (e.g., enzymes, antibodies) were noted, and the data in question were excluded from the final reports. Frequencies of each cell type were averaged for each microbial colonization condition.
IgA ELISA IgA levels in feces of monocolonized mice were measured with a Mouse IgA Elisa Kit (eBioscience, according to the manufacturer's instructions.
Gene-expression profiling

Data collection
The same segments of the distal colon (0.5 cm long and 3 cm away from the rectum) and three segments (each 0.3 cm long) from the same midsection of the duodenum, jejunum, and ileum of the small intestine were collected from mice. These segments were then homogenized in TRIzol and stored at À80 C until RNA isolation. GF samples were collected throughout the duration of the screen. Samples were collected from both female and male mice. Colon profiling included a total of four batches of samples totaling 56 samples from male mice and 16 samples from female mice. SI profiling included a total of four batches of samples totaling 51 samples from male mice and 7 samples from female mice. Each batch of microbially colonized intestines was profiled together with at least two replicates of GF control samples. Profiling was performed on Affymetrix Mouse Genome M1.0 ST arrays as previously described (Cipolletta et al., 2012) , nearly always at least in duplicate (singletons in rare instances).
QUANTIFICATION AND STATISTICAL ANALYSIS Immunophenotypes
Fold-change values were calculated by dividing the frequencies of a given cell type for each microbial colonization by the average frequency obtained from GF mice. To control for multiple testing, a false discovery rate was calculated by the Benjamini-Hochberg procedure (Benjamini and Hochberg, 1995) ; the thresholds used are indicated in the text and figures where relevant.
Pearson correlations (for normalized mean immunophenotypes) and Euclidean distances (either per mouse or per normalized mean) within phyla, genera, species, or strains were calculated by GeneE. To normalize per cell type, each frequency was divided by the mean of the cell type of interest across all microbes.
Gene expression profiling Data normalization and batch correction Microarray data were background-corrected and normalized with the robust multi-array average algorithm. Gender and batch effects were corrected in a linear model with the feature as dependent variable and technical variables (batches) as regressors (implemented by R package ''swamp''). CV calculation Microarrays for each microbe were typically performed in duplicate or triplicate. Thus, the CV per transcript for GF intestines was determined by (1) calculating the CV per transcript for randomly sampled GF pairs from a total of 8 (SI) or 12 (colon) GF replicates, and (2) iterating the random sampling 250 times and taking the average of the 250 CV values as the final CV value for GF mice. CV values for microbially colonized samples were calculated as per normal, without random sampling. Selection of differentially expressed genes Analysis on the whole tissue transcriptome focused on a select set of genes with a fold change relative to GF of > 2.5 (or < 0.4) and uncorrected p(-log 10 ) > 2.5. Scatter analysis for most extreme effects on transcripts (both as fold change and as t test p value) was performed in R-Project or Multiplot Studio. AMP aggregate score and correlation with gene expression Aggregate AMP scores were calculated as follows: (1) RNA levels for each transcript belonging to the a-defensin and Reg3 family of AMPs, for which changes in expression levels were most dynamic, were normalized to the mean expression level across all samples; and (2) the normalized transcript levels were then summed and averaged for each sample to derive an aggregate AMP score. The correlation of all other transcripts with the respective AMP scores was determined with the Spearman correlation test. Correlations were calculated separately for GF and colonized mice, with use of six randomly sampled replicates for either group and iteration of the sampling and correlation test 50 times. The mean of the 50 correlation coefficients was taken to be the final coefficient value. RNAs with a correlation coefficient of > 0.6 for both GF and monocolonized mice were extracted for pathway enrichment analysis. Clustering and enrichment analysis Hierarchical clustering and K-means clustering were performed on these selected genes in GeneE. Pathway analysis was done with STRING (www.string-db.org) and Enrichr Kuleshov et al., 2016 , http://amp.pharm.mssm.edu/Enrichr/). Enrichment for cell types was verified in ImmGen and GNF databases.
DATA AND SOFTWARE AVAILABILITY
The extensive datasets presented in Figures 1, 2, 3 , and 4 are available for mining (Tables S1, S2, S3). Phylogenetic identity of all bacteria is detailed in Table S1A . The immunophenotypes as frequencies of cell types per an invidiual mouse basis are presented in Table S2D . The accession number for the gene expression raw data reported in this paper is GEO: GSE88919. 
Supplemental Figures
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Gating strategy for CD4 T cell cytokines Table S2 (A and B) (A) Rank-ordered average frequencies of each immunocyte population for every monocolonized microbe in SI and PP, as measured by flow cytometry.
(B) Rank-ordered average frequencies of each immunocyte population for every monocolonized microbe in mLN and SLO, as measured by flow cytometry. For cell-type frequency determination (y-axis) and bacterial identification (x-axis), see Tables S1B, S2A , and S2B. For gating strategies, see Figure S1 .
(legend continued on next page) 
